Pan-European real estate investment and development group, Eurofund Group, has launched a new senior living platform. Luana is an independent senior living platform that will offer professionally mana...
These transactions, with a combined value of approximately €80 million, are fully aligned with Healthcare Activos' investment principles: sustainable rents in long triple net leases with fixed rent ...
Since its initial investment, H.I.G. has supported Deenova’s international growth through strategic acquisitions and the strengthening of its management team. The Company has become an industry lead...
SANTALUCÍA, la aseguradora líder en protección integral para las familias, se ha convertido en inversor de referencia de Korion Life Sciences FCR, un Fondo de Fondos de Capital Riesgo con sede en M...
Columbus Venture Partners is supporting the management of this fund through a joint venture whereby both firms combine their investment experience in Venture Capital, Private Equity and Healthcare. To...
The funding round was led by Leadwind, Kfund’s early growth fund,, with participation from Index Ventures, Kaszek, and IDB Lab. The investment highlights Sofía’s success and the trust it has gene...
La sociedad de capital riesgo Unirisco, participada por las universidades gallegas, varias de las principales empresas de la región y el Banco Santander, se incorpora al accionariado de Gazella Biote...
En la actualidad, Deeplabs opera en dos distritos, MASID y BASID, en Madrid y Barcelona respectivamente, con tres campus en funcionamiento: Tres Cantos y Fuencarral en MASID, y Esplugues de Llobregat ...
La inversión del Telescope Biotech Fund sigue una metodología altamente especializada, con una selección cuidada y rigurosa de compañías biotech y farmacéuticas. La firma identifica las tecnolog...
The growing demand for innovative and technological medical solutions, as well as the aging population and the increase in life expectancy mean that the MedTech sector is experiencing significant grow...
H.I.G. Capital, a leading global alternative investment firm with $67 billion of capital under management, is pleased to announce that an affiliate has signed a strategic partnership with Queen Mary B...
Neumirna was founded with the mission to revolutionize the treatment paradigms for challenging neurological conditions, and is at the forefront of RNA therapeutics, harnessing the power of microRNAs (...